Immunotherapy effect of durvalumab/Infinifer

Durvalumab/Infinifer (Durvalumab) is an immune checkpoint inhibitor that mainly works by targeting the PD-L1 receptor, activating the human immune system and enhancing the recognition and attack of tumor cells by T cells. It helps the patient's immune system actively attack and eliminate cancer cells by removing the suppression of the immune system by tumor cells. In recent years, durvalumab/Infinifer has achieved significant clinical results in the treatment of various cancers.

Imrvalumab has shown outstanding efficacy in the treatment of non-small cell lung cancer ( NSCLC), particularly in patients with advanced stages of inoperable or metastatic disease. Compared with traditional chemotherapy, immunotherapy can provide longer-lasting efficacy and lower side effects, making it an important treatment option for patients with advanced non-small cell lung cancer. By lifting the inhibition of the PD-1/PD-L1 pathway, durvalumab can promote immune cells to recognize tumor cells and eliminate them, significantly improving patient survival rates.

Irvalumab has also shown good efficacy in urothelial cancer, especially bladder cancer. When traditional treatments such as chemotherapy are ineffective, durvalumab has become an important treatment option, which can effectively control the disease and improve the survival of some patients. In addition, the efficacy of durvalumab has been gradually confirmed in a variety of other tumor types, such as head and neck squamous cell carcinoma (HNSCC).

Compared with traditional chemotherapy, durvalumab has obvious advantages. Common side effects during its treatment are relatively mild, and it does not damage normal cells as seriously as chemotherapy. As a result, patients generally have a higher quality of life and longer-lasting responses to treatment.

The immunotherapy effect of durvalumab is not only reflected in the control of cancer, but also significantly improves the prognosis of patients, especially those in advanced stages where traditional treatments are ineffective.

Reference materials:https://www.imfinzi.com/